COVID-19 patterns in patients with MPNs in the first versus second waves

COVID-19 and MPN updatesПодробнее

Assessing COVID-19 infection rates in patients with AML and MPNПодробнее

Impact of COVID-19 on MPNs patientsПодробнее

Outcomes of MPN patients versus non-MPN patients hospitalized for COVID-19Подробнее

COVID-19 and MPNПодробнее

Coronavirus and myeloproliferative neoplasms MPNsПодробнее

The latest updates on COVID-19 and MPNsПодробнее

COVID-19 occurrence and impact in hematological oncology patientsПодробнее

MPNs and COVID-19Подробнее

Antibody and T-cell responses to COVID-19 vaccination in myeloproliferative neoplasm patientsПодробнее

MPN Voice Patient Forum Belfast 13 Nov 2021Подробнее

What are the long-term effects of COVID-19 in patients with MPN?Подробнее

Antibody and T-cell responses to COVID-19 vaccination in patients with MPNsПодробнее

MPNs and Coronavirus: What Patients Should KnowПодробнее

MPN Voice 'Virtual' Patients' Forum London 25 August 2021Подробнее

Conversation with MPN Specialists: Focus on Essential ThrombocythemiaПодробнее

MPN Voice Patients' virtual forum London 2 Feb 2021Подробнее

Myeloproliferative neoplasms around the COVID-19 pandemic - Professor Tiziano BarbuiПодробнее

Is the COVID-19 Vaccine Safe and Effective for MPN Patients?Подробнее